Quick Answer
Kiniksa Pharmaceuticals International, plc reported Net Income of $59.01 million for fiscal year 2025.
Kiniksa Pharmaceuticals International, plc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $59.01M | +236.6% |
| 2024 | -$43.19M | -406.7% |
| 2023 | $14.08M | -92.3% |
| 2022 | $183.36M | +216.1% |
| 2021 | -$157.92M | +2.1% |
| 2020 | -$161.38M | +0.3% |
| 2019 | -$161.87M | -56.8% |
| 2018 | -$103.23M | -59.1% |
| 2017 | -$64.87M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.43M | +245.2% | +3.4% |
| June 30, 2025 | $17.83M | +556.3% | +108.8% |
| March 31, 2025 | $8.54M | +148.2% | +167.3% |
| September 30, 2024 | -$12.69M | +8.4% | -224.8% |
| June 30, 2024 | -$3.91M | -126.1% | +77.9% |
| March 31, 2024 | -$17.70M | -44.3% | -27.8% |
| September 30, 2023 | -$13.86M | -106.2% | -192.5% |
| June 30, 2023 | $14.97M | +174.9% | +222.0% |
- Kiniksa Pharmaceuticals International, plc showed an increase of +236.6% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Kiniksa Pharmaceuticals International, plc’s net income has grown by 191.0% (from -$64.87 million to $59.01 million).
- The most recent figure is from Kiniksa Pharmaceuticals International, plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: